1,792
Views
0
CrossRef citations to date
0
Altmetric
Transplantation

Graft survival and mortality outcomes after kidney transplant in patients with lupus nephritis: a systematic review and meta-analysis

, &
Article: 2296000 | Received 11 Sep 2023, Accepted 12 Dec 2023, Published online: 04 Jan 2024

References

  • Ameer MA, Chaudhry H, Mushtaq J, et al. An overview of systemic lupus erythematosus (SLE) pathogenesis, classification, and management. Cureus. 2022;14(10):1. doi:10.7759/cureus.30330.
  • Apostolidis SA, Lieberman LA, Kis-Toth K, et al. The dysregulation of cytokine networks in systemic lupus erythematosus. J Interferon Cytokine Res. 2011;31(10):769–10. doi:10.1089/jir.2011.0029.
  • Aringer M, Smolen JS. Efficacy and safety of TNF-blocker therapy in systemic lupus erythematosus. Expert Opin Drug Saf. 2008;7(4):411–419. doi:10.1517/14740338.7.4.411.
  • Barber MRW, Drenkard C, Falasinnu T, et al. Global epidemiology of systemic lupus erythematosus. Nat Rev Rheumatol. 2021;17(9):515–532. doi:10.1038/s41584-021-00668-1.
  • Bunnapradist S, Chung P, Peng A, et al. Outcomes of renal transplantation for recipients with lupus nephritis: analysis of the organ procurement and transplantation network database. Transplantation. 2006;82(5):612–618. doi:10.1097/01.tp.0000235740.56573.c6.
  • Chelamcharla M, Javaid B, Baird BC, et al. The outcome of renal transplantation among systemic lupus erythematosus patients. Nephrol Dial Transplant. 2007;22(12):3623–3630. doi:10.1093/ndt/gfm459.
  • Croca SC, Rodrigues T, Isenberg DA. Assessment of a lupus nephritis cohort over a 30-year period. Rheumatology (Oxford). 2011;50(8):1424–1430. doi:10.1093/rheumatology/ker101.
  • Deegens JKJ, Artz MA, Hoitsma AJ, et al. Outcome of renal transplantation in patients with systemic lupus erythematosus. Transpl Int. 2003;16(6):411–418. doi:10.1007/s00147-003-0563-9.
  • Derner O, Kramer A, Hruskova Z, et al. Incidence of kidney replacement therapy and subsequent outcomes among patients with systemic lupus erythematosus: findings from the ERA registry. Am J Kidney Dis. 2022;79(5):635–645. doi:10.1053/j.ajkd.2021.09.016.
  • Ding Y, Tan Y, Qu Z, et al. Renal microvascular lesions in lupus nephritis. Ren Fail. n.d;42(1):19–29. doi:10.1080/0886022X.2019.1702057.
  • Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634. doi:10.1136/bmj.315.7109.629.
  • Fava A, Petri M. Systemic lupus erythematosus: diagnosis and clinical management. J Autoimmun. 2019;96:1–13. doi:10.1016/j.jaut.2018.11.001.
  • Frutos MÁ, Crespo M, Valentín M, et al. Recommendations for living donor kidney transplantation. Nefrologia (Engl Ed). 2022;42(Suppl 2):5–132. doi:10.1016/j.nefroe.2022.07.001.
  • Hoover PJ, Costenbader KH. Insights into the epidemiology and management of lupus nephritis from the US rheumatologist’s perspective. Kidney Int. 2016;90(3):487–492. doi:10.1016/j.kint.2016.03.042.
  • Horta-Baas G, Camargo-Coronel A, Miranda-Hernández DG, et al. Renal transplantation in systemic lupus erythematosus: comparison of graft survival with other causes of end-stage renal disease. Reumatol Clin (Engl Ed). 2019;15(3):140–145. doi:10.1016/j.reuma.2017.07.006.
  • Kim JE, Kim YC, Min S-L, et al. Transplant outcomes in kidney recipients with lupus nephritis, and systematic review. Lupus. 2020;29(3):248–255. doi:10.1177/0961203320902524.
  • Kostopoulou M, Fanouriakis A, Cheema K, et al. Management of lupus nephritis: a systematic literature review informing the 2019 update of the Joint EULAR and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations. RMD Open. 2020;6(2):e001263. doi:10.1136/rmdopen-2020-001263.
  • Lee D, Kanellis J, Mulley WR. Allocation of deceased donor kidneys: a review of international practices. Nephrology (Carlton). 2019;24(6):591–598. doi:10.1111/nep.13548.
  • Lionaki S, Kapitsinou PP, Iniotaki A, et al. Kidney transplantation in lupus patients: a case-control study from a single centre. Lupus. 2008;17(7):670–675. doi:10.1177/0961203308089430.
  • McGuinness LA, Higgins JPT. Risk-of-bias VISualization (robvis): an R package and shiny web app for visualizing risk-of-bias assessments. Res Synth Methods. 2021;12(1):55–61. doi:10.1002/jrsm.1411.
  • Moroni G, Tantardini F, Gallelli B, et al. The long-term prognosis of renal transplantation in patients with lupus nephritis. Am J Kidney Dis. 2005;45(5):903–911. doi:10.1053/j.ajkd.2005.01.038.
  • Murimi-Worstell IB, Lin DH, Nab H, et al. Association between organ damage and mortality in systemic lupus erythematosus: a systematic review and meta-analysis. BMJ Open. 2020;10(5):e031850. doi:10.1136/bmjopen-2019-031850.
  • Naranjo-Escobar J, Manzi E, Posada JG, et al. Kidney transplantation for end-stage renal disease in lupus nephritis, a very safe procedure: a single Latin American transplant center experience. Lupus. 2017;26(11):1157–1165. doi:10.1177/0961203317696591.
  • Nieto-Ríos JF, Serna-Higuita LM, Builes-Rodriguez SA, et al. Clinical outcomes of kidney transplants on patients with end-stage renal disease secondary to lupus nephritis, polycystic kidney disease and diabetic nephropathy. Colombia Medica (Cali, Colombia). 2016;47(1):51–58. doi:10.25100/cm.v47i1.2085.
  • Norby GE, Leivestad T, Mjøen G, et al. Premature cardiovascular disease in patients with systemic lupus erythematosus influences survival after renal transplantation. Arthritis Rheum. 2011;63(3):733–737. doi:10.1002/art.30184.
  • Ohmes J, Comdühr S, Akbarzadeh R, et al. Dysregulation and chronicity of pathogenic T cell responses in the pre-diseased stage of lupus. Front Immunol. 2022;13:1007078. doi:10.3389/fimmu.2022.1007078.
  • Page MJ, McKenzie JE, Bossuyt PM, et al. PRISMA. Transparent reporting of systematic reviews and meta-analyses. BMJ. 2021;372:n71. doi:10.1136/bmj.n71.
  • Pampa-Saico S, Marcén-Letosa R, Fernández-Rodríguez A, et al. Kidney transplantation in systemic lupus erythematosus: outcomes and prognosis. Med Clin (Barc). 2019;153(12):460–463. doi:10.1016/j.medcli.2018.09.016.
  • Pan L, Lu M-P, Wang J-H, et al. Immunological pathogenesis and treatment of systemic lupus erythematosus. World J Pediatr. 2020;16(1):19–30. doi:10.1007/s12519-019-00229-3.
  • Ramirez-Sandoval JC, Chavez-Chavez H, Wagner M, et al. Long-term survival of kidney grafts in lupus nephritis: a Mexican cohort. Lupus. 2018;27(8):1303–1311. doi:10.1177/0961203318770527.
  • Segura BT, Bernstein BS, McDonnell T, et al. Damage accrual and mortality over long-term follow-up in 300 patients with systemic lupus erythematosus in a multi-ethnic British cohort. Rheumatology (Oxford). 2020;59(3):524–533. doi:10.1093/rheumatology/kez292.
  • Sekercioglu N, Fu R. Operations research to solve kidney allocation problems: a systematic review. Healthcare (Basel). 2023;11(5):768. doi:10.3390/healthcare11050768.
  • Sharif A. Deceased donor characteristics and kidney transplant outcomes. Transpl Int. 2022;35:10482. doi:10.3389/ti.2022.10482.
  • Sterne JA, Hernán MA, Reeves BC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919. doi:10.1136/bmj.i4919.
  • Tektonidou MG, Dasgupta A, Ward MM. Risk of end-stage renal disease in patients with lupus nephritis, 1971-2015: a systematic review and Bayesian meta-analysis. Arthritis Rheumatol. 2016;68(6):1432–1441. doi:10.1002/art.39594.
  • Wells G, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. 2013. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp.
  • Wu DA, Watson CJ, Bradley JA, et al. Global trends and challenges in deceased donor kidney allocation. Kidney Int. 2017;91(6):1287–1299. doi:10.1016/j.kint.2016.09.054.
  • Yu TM, Chen YH, Lan JL, et al. Renal outcome and evolution of disease activity in Chinese lupus patients after renal transplantation. Lupus. 2008;17(7):687–694. doi:10.1177/0961203308089439.
  • Zhang H, Chen J, Zhang Y, et al. Efficacy and safety of belimumab therapy in lupus nephritis: a systematic review and meta-analysis. Ren Fail. n.d.;45(1):2207671. doi:10.1080/0886022X.2023.2207671.
  • Zhang L, Lee G, Liu X, et al. Long-term outcomes of end-stage kidney disease for patients with lupus nephritis. Kidney Int. 2016;89(6):1337–1345. doi:10.1016/j.kint.2016.02.014.
  • Zhao H, Alam A, Soo AP, et al. Ischemia-Reperfusion injury reduces long term renal graft survival: mechanism and Beyond. EBioMedicine. 2018;28:31–42. doi:10.1016/j.ebiom.2018.01.025.